Acto Technologies Inc.
$417,679.00
Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada
AI Compute Access Fund
FY 2025-2026
Canada
ACTO will advance PharmaForce and CxZone to improve training, knowledge access and customer engagement in life sciences, enabling safe, scalable AI and faster time-to-competency.